A Non-interventional Pharmacovigilance Study of Osteonecrosis of the Jaw and Infection Leading to Hospitalization Among Patients With Cancer Treated With
XGEVA™ or Zoledronic Acid in Sweden, Denmark, and Norway (20101363)

First published 11/02/2020

Last updated 05/08/2020

EU PAS number:

EUPAS32437

Study

Finalised

Documents

Study protocol

Initial protocol

20101363_01.02.06 Public Redacted Protocol Ver 1.0 2016-06-29 English

English (417.83 KB - PDF)View document

Study results

Clinical Study Report 2020-01-07 20101363 ORSR Abstract

English (340.91 KB - PDF)View document

Study report

Other information

Secondary tabs